Global Urinary Tract Infection Testing Market

Urinary Tract Infection Testing Market Size, Share, Growth Analysis, By Infection Type(Urethritis, Cystitis, and Pyelonephritis), By Test Type(Urinalysis, Urine Cultures, Susceptibility Testing), By End-user(Hospitals, Diagnostic Laboratories, Research Institutes), By Test Kit(Home Test Kits, Laboratory Test Kits), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35D2169 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 116 | Figures: 77

Urinary Tract Infection Testing Market News

  • In January 2024, Vivoo, a wellness application offering personalized nourishment and way-of-life counseling utilizing at-home urine tests, presented its computerized Urinary Tract Infection (UTI) testing item at CES 2024.

     

  • In February 2024, Recce Pharmaceuticals Ltd, an organization fostering another kind of synthetic anti-infective drugs, reported its continuous work at the Murdoch Children’s Research Institute (MCRI) in its Anti-Infective Research (AIR) Unit. The organization intends to smooth out its preclinical projects and investigate new purposes for future clinical trials.

     

  • In February 2024, Recce Drugs Ltd., an organization having some expertise in another class of synthetic anti-infectives, uncovered the marking of a Memorandum of Understanding (MoU) with PT Etana Biotechnologies, a conspicuous Indonesian biomedical organization. The joint effort plans to facilitate the clinical advancement of Recce's anti-infective portfolio in Indonesia, tending to the pressing worldwide medical problem of antimicrobial resistance (AMR).

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Urinary Tract Infection Testing Market size was valued at USD 9.06 Billion in 2023 and is poised to grow from USD 9.43 Billion in 2024 to USD 13 Billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The competitive landscape of the global urinary tract infection (UTI) market is characterized by a diverse array of players vying for market share. Established diagnostics and pharmaceutical companies, as well as innovative startups, contribute to the market's dynamism. These entities focus on developing advanced diagnostic tools, therapeutic solutions, and innovative treatment approaches to address the growing burden of UTIs. The competitive scenario is driven by a continuous quest for improved accuracy, faster results, and patient-friendly testing methods. 'QIAGEN (Germany)', 'Accelerate Diagnostics, Inc. (US)', 'Bio-Rad Laboratories, Inc. (US)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Danaher Corporation (US)', 'Siemens Healthcare GmbH (Germany)', 'Randox Laboratories Ltd. (UK)', 'Thermo Fisher Scientific, Inc. (US)', 'bioMérieux SA (France)', 'T2 Biosystems, Inc. (US)', 'Beckman Coulter, Inc. (US)', 'Becton, Dickinson and Company (US)', 'Sysmex Corporation (Japan)', 'Cepheid (US)', 'GenMark Diagnostics, Inc. (US)', 'Hologic, Inc. (US)', 'Ortho Clinical Diagnostics (US)', 'Luminex Corporation (US)', 'Bruker Corporation (US)', 'Trinity Biotech plc (Ireland)'

The global urinary tract infection (UTI) market is significantly influenced by the escalating prevalence of antibiotic resistant UTIs. The overuse and misuse of antibiotics have led to the emergence of bacteria that are resistant to traditional treatments, complicated UTI management. This pressing concern has driven the need for accurate diagnostic tools such as urine cultures and susceptibility testing, enabling healthcare providers to identify effective treatment options tailored to specific bacterial strains. Additionally, the urgency to contain antibiotic resistance has spurred investments in research and development for novel therapies, further shaping the market's dynamics toward innovative solutions that combat resistant UTIs while promoting prudent antibiotic use.

Rise of Point-of-Care (POC) Testing: In the global urinary tract infection (UTI) market, a prominent trend is the increasing adoption of Point-of-Care (POC) testing methods. POC tests offer rapid results and convenient on-site diagnostics, eliminating the need for centralized laboratory facilities and reducing turnaround times. This trend aligns with the demand for quick and accurate UTI diagnosis, especially in primary care settings. The integration of POC testing technologies empowers healthcare professionals to make timely treatment decisions, improve patient outcomes, and optimize resource allocation. As technology advancements continue to enhance the accuracy and efficiency of POC tests, their widespread implementation is reshaping the landscape of UTI diagnostics.

North America emerges as the dominating force in the global urinary tract infection (UTI) market. This is attributed to its well-established healthcare infrastructure, high prevalence of UTIs, and strong emphasis on research and development. Additionally, a heightened awareness about UTIs among the population and swift adoption of advanced diagnostic technologies further fuel market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Urinalysis Test Market
Buy Now GET FREE SAMPLE
Antimicrobial Susceptibility Testing Market
Buy Now GET FREE SAMPLE
Rapid Microbiology Testing Market
Buy Now GET FREE SAMPLE
Drug Testing Market
Buy Now GET FREE SAMPLE
Kidney Function Test Market
Buy Now GET FREE SAMPLE
Urology Devices Market
Buy Now GET FREE SAMPLE
Urinary Catheter Market
Buy Now GET FREE SAMPLE
Urinary Catheters Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Urinary Tract Infection Testing Market

Report ID: SQMIG35D2169

$5,300
BUY NOW GET FREE SAMPLE